| Literature DB >> 33132144 |
He Xie1, Honggang Sun2, Rongrong Mu3, Shilin Li4, Yujia Li5, Chunhui Yang6, Min Xu7, Xiaoqiong Duan8, Limin Chen9.
Abstract
Circular RNAs (circRNAs) are a class of non-coding RNAs with a special covalently closed circular structure, which is formed by precursor mRNA (pre-mRNA) through "back-splicing". CircRNAs are more stable than linear RNAs because they are resistant to exoribonucleases. Viral infections often cause abnormal expression of circRNAs, which could serve as novel biomarkers for the diagnosis of viral infections by detecting specific circRNAs in cells, body fluids, or tissues. CircRNAs also play a critical role in regulating host immune response and virus replication. Here, we reviewed the production and function of circRNAs, mainly focusing on their regulation on virus infection, to provide novel insights into the potential role of circRNAs as diagnostic marker or treatment targets for viral infection.Entities:
Keywords: Circular RNAs; Diagnostic marker; Treatment targets; Virus
Year: 2020 PMID: 33132144 PMCID: PMC7581343 DOI: 10.1016/j.virusres.2020.198205
Source DB: PubMed Journal: Virus Res ISSN: 0168-1702 Impact factor: 3.303
Fig. 1Formation and function of circRNAs. (A) The cis-acting elements and trans-acting factors participate in circularization. The cis-acting element allows the introns flanking exons directly base pair into circularization through SINEs. Trans-acting factor driving circularization by binding to specific sites of introns flanking exons. Among them, MBL and QKI promote cyclization, while ADAR1 inhibits circRNAs formation. (B, C) Lariat-driven circularization mode includes exon skipping and intron removal toform EIciRNAs and ciRNAs respectively. (D) CircRNAs act as miRNA sponges to inhibit the interaction between miRNAs and their target mRNAs. (E) Circ RNAs directly bind RBPs to affect gene expression. (F) CircRNAs directly bind RBPs to affect gene expression. (G) CircRNAs interact with U1 snRNP to form circRNAs-U1 snRNP complexes and regulate gene transcription in the nucleus. (H) RNA-DNA hybrid strand regulates its parental DNA transcription by a negative feedback loop. (I) CircRNAs are packed into exosomes and involved in cell-to-cell signal transmission. (J) Some circRNAs exists freely in various body fluids such as blood, saliva, and urine, together with exosomes circuRNAs can be used as biomarkers for disease diagnosis.
Virus-derived circRNAs.
| Virus | Sample type | Virus-derived circRNAs | Reference |
|---|---|---|---|
| HPV | TCGA RNA-Seq data from HPV-positive cancers | HPV16 circE7 | ( |
| HBV | HBV-infected HepG2 cells, HepAD38 cells and human primary hepatocytes | HBV circRNA | ( |
| BCLCaV | BCLCaV-infected Ribes nigrum and Nicotiana benthamiana tissue | circular forms of BCLCaV RNA-2 and RNA-3 | ( |
| rLCV SIV | SIV/LCV-infected rhesus lymphoma model | rLCV circRPMS1_E5_E3a EBV circRPMS1_E4_E3a circRPMS1_E2b_E1b circEBNA_U | ( |
| MHV68 | MHV68-infected NIH 3T12 cells | MHV68 circM11_ORF69 | |
| KSHV | KSHV positive BCBL-1 cells | KSHV circvIRF4 | |
| KSHV | KSHV-infected HUVECs or infected B cell line, MC116 | KSHV circvIRF4 | ( |
| EBV | EBV-infected cell lines, including SNU-719, AGS-EBV, C666-1 and Akata | EBV circ_RPMS1 | ( |
| EBV | Represent type I, II, and III latency transcription programs and during reactivation period lymphocyte gastric cancer cell models infected with EBV | circEBNA_U、circBHLF1 circRPMS1_E4_E3a circRPMS1_E4_E2 circEBNA_W1_C1 circEBNA_W2_C1 circLMP2_E8_E2 | ( |
| EBV | EBV-positive PTLDs | circBARTs | ( |
| KSHV | DMSO-treated or NaB/TPA-induced KSHV-infected PEL cell lines BCBL1 and BC-1 | circvIRF4, circPANs/K7.3 |
TCGA, The Cancer Genome Atlas; rLCV, rhesus macaque lymphocryptovirus; SIV, simian immunodeficiency virus; HUVECs, HUVEC-human umbilical vein endothelial cells; PTLD, posttransplant lymphoproliferative disease.
Differentially expressed host circRNAs in human following virus infection.
| Virus | Sample type | Name of circRNAs with differentially expressed | Expression level | Reference |
|---|---|---|---|---|
| HTNV | HTNV-infected HUVECs | hsa_circ_0000479 | Up-regulated | ( |
| HBV | Blood and liver tissues from CHB patients, HBV-infected hepatoma cells | hsa_circ_0004812 | Up-regulated | ( |
| HBV | Liver biopsies from untreated CHB patients | hsa_circ_0005389 | Upregulated | ( |
| hsa_circ_0000650 | Down-regulated | |||
| HIV | PBMC of HARRT-naive EHI patients | hsa_circ_0000711 hsa_circ_0006968 | EHI group compared with HC group: up-regulated | ( |
| PBMCs of HARRT-naive CHI patients | hsa_circ_0003863 hsa_circ_0049083 | CHI group compared with EHI group: up-regulated | ||
| IAV H1N1 | H1N1-infected A549 cells | hsa_circ-GATAD2A | Up-regulated | ( |
| HCMV | HCMV latent-infected THP-1 cells | hsa_circ_0001445 hsa_circ_0001206 | Down-regulated | ( |
| KSHV | KSHV-infected HUVECs, B cell line, MC116 | hsa_circ_0001400 hsa_circ_0001741 hsa_circ_0008311 hsa_circ_0005145 | Up-regulated | ( |
| HSV-1 | HSV-1 infected KMB17 cells | hsa_circRNA3046 hsa_circRNA3683 hsa_circRNA6783 hsa_circRNA7752 hsa_circRNA7231 | Up-regulated | ( |
HTNV, hantaan virus; HIV-1, human immunodeficiency virus type 1; IAV, influenza A virus; HSV-1, herpes simplex virus; HCs, healthy controls; PBMC, Peripheral blood mononuclear cell; HARRT, Highly Active Antiretroviral Therapy; EHI, early HIV infection; CHI, chronic HIV infection.
Mechanisms of circRNAs regulation in viral replication and related disease.
| CircRNA | Effect on virus | Regulated pathway | Refer-ence |
|---|---|---|---|
| circ_0000479 | Overexpression promotes the expression of RIG-I and hampering HTNV replication | circ_0000479/ miR-149-5p/ RIG-I pathway | ( |
| hsa_circ_0004812 | Knockdown expression promotes the IFN-α/β, and inhibits HBV replication. | circ_0004812/ miR-1287-5p/ FSTL1 axis to regulate IFN-induced immune response | ( |
| circRNA_100338 | Overexpression enhanced migratory and invasive ability of cancer cells | circRNA_100338 / miR-1413p axis to regulate invasive potential in liver cancer cells | ( |
| circ-GATAD2A | Knockdown expression enhances autophagy and inhibits IAV H1N1 replication, reverse after overexpression | circ-GATAD2A/ VPS34-dependent autophagy pathway | ( |
| circ-Vav3 | Overexpression induces EMT, promote ALV-J related tumorigenesis | circ-Vav3/gga-miR-375/YAP1 axis induces EMT pathway | ( |
| circEZH2 | Overexpression inhibits TGEV-induced mPTP opening and regulate NF-κB activation | circEZH2/ miR-22/ HK2 axis, circEZH2 /miR-22/IL-6/ NF-Kb pathway to regulate mPTP opening | ( |